About Sam Barnum

This author has not yet filled in any details.
So far Sam Barnum has created 32 blog entries.

NCCN 2021 Conference Highlights: Elevating Racial Equity in Cancer Care

2021-04-06T16:36:33-04:00

The NCCN 2021 Annual Conference convened virtually March 18-20, drawing attendees from more than 40 countries to discuss updates to NCCN's Oncology Clinical Practice Guidelines, new and emerging therapies, best practices in oncology care, as well as keynote sessions on HPV vaccinations, racial disparities in guideline-adherent cancer care, and effects of the pandemic on cancer care.

NCCN 2021 Conference Highlights: Elevating Racial Equity in Cancer Care2021-04-06T16:36:33-04:00

BHA Partners with Alcon to Conduct Real-World Study Highlighting Efficiencies of Optical Biometer in Cataract Surgery

2020-12-15T16:09:39-05:00

Alcon, a global leader in eye care, collaborated with Boston Healthcare to conduct a Time-and-Motion Study to support the value communication of its novel swept-source optical coherence tomography biometer, ARGOS®.

BHA Partners with Alcon to Conduct Real-World Study Highlighting Efficiencies of Optical Biometer in Cataract Surgery2020-12-15T16:09:39-05:00

China Payment Reform: 2020 Update

2020-11-03T17:26:56-05:00

The pilot of implementing a diagnosis-related group (DRG) payment model to inpatient hospital care, a major initiative of China’s ongoing healthcare reform, started in 2019. Boston Healthcare Associates has been vigilant in tracking this strategic topic given the implications on the industry and the healthcare ecosystem as a whole.

China Payment Reform: 2020 Update2020-11-03T17:26:56-05:00

CMS Proposes Changes to Part B Medicare Reimbursement for Physician-Administered Drugs Approved Under the 505(b)(2) Approval Pathway

2020-11-02T11:46:40-05:00

The Centers for Medicare and Medicaid Services (CMS) intends to alter assignment of Healthcare Common Procedure Coding System (HCPCS) Level II codes for certain physician-administered 505(b)(2) drugs. 

CMS Proposes Changes to Part B Medicare Reimbursement for Physician-Administered Drugs Approved Under the 505(b)(2) Approval Pathway2020-11-02T11:46:40-05:00
Go to Top